PDF Page 1
10:45:46a.m.
XXXXXXXXXX
XXXX
123
Patient: I
Printed by:
MRN:
Printed on: XXXXXXXXXX 09:18
>>>>>>>> PATIENT INFORMATION <<<<<<<<
Name:
Sex: XXXXXX Date of Birth:
Age: XX Years MS: Single
Previous Name:
Social XXXXXXXX Number:
Race: Black or XXXXXXXXXXXXXXXX
Ethnicity: Non-Hispanic or Latino
Language: English
Religion: None
Home Address:
XXXXXXXXXX:
Zip:
Alt Address: XXXXXXXXXX:
Zip:
Home Phone:
Cell Phone:
Employer Name: NONE
Employer Phone:
Employer Address:
XXXXXXXXXX:
Zip:
XXXXXXXXXXXXXXXXXXXXX <<<<<<<<
Name:
Sex: XXXXXX Date of Birth:
Age: XX Years
Relationship to XXXXXXXXX: Patient
Social XXXXXXXX Number:
Billing Address:
XXXXXXXXXX:
Zip:
Home Phone:
Employer Name: NONE
Employer Phone:
XXXXXXXXXXXXXXXX:
XXXXXXXXXX:
Employment Status: Not Employed
>>>>>>>> EMERGENCY CONTACT INFORMATION <<<<<<<<
Name:
Relationship to Contact:
Home Address:
XXXXXXXXXX:
Zip:
Home Phone:
Cell Phone:
PRIMARY INSURED/INSURANCE INFORMATION <<<<<
Name:
Sex: XXXXXX Date of Birth:
Age: XX Years
Relationship to Insured:
Employer Name: NONE
Employer Address:
XXXXXXXXXX:
Employment Status: Not Employed
Zip:
Employer Phone:
Insurance Name: BLUE CROSS COMMUNITY HEALTH PLAN MEDICAID
Policy Number:
x
Phone Number:
Claim's Address: XXXXXXXXXXXXXXXXXXXXXXXX. Number:
Auth. Phone Number:
XXXXXXXXXXX
XXXXXXXXXXXX:
XXXXXXXXXX: XXXXXXXXXXXXXXXX: XXXXX
>>>>> SECONDARY INSURED/INSURANCE INFORMATION <<<<<
NO SECONDARY INSURED/INSURANCE INFORMATION
>>>>>>>> VISIT INFORMATION <<<<<<<<
Reg Date/Time: XXXXXXXXXX 01:12
Patient Type: Behavioral Health Adult
Inpatient Admit Date/Time: XXXXXXXXXX 01:23
OP Assign to Loc Date/Time:
Admit Type: Elective
Admit Clerk:
Admit Source: Xfer from a Hospital
FIN:
Admit Diagnosis: EVALUATION
Estimated Date of Arrival: XXXXXXXXXX 23:55
Discharge Date/Time:
Discharge Disposition:
Admitting Physician Name:
Attending Physician Name:
Referring Physician Name:
Primary Physician Name:
Advance Directive:
Location:
Room/Bed:
Medical Service: Psychiatry
>>>>>>>> ACCIDENT INFORMATION <<<<<<<<
Accident Date/Time:
Accident Type:

PDF Page 2
123
10:46:14 a.m.XXXXXXXXXX3XXXX2
PDF Page 3
123
10:46:22 a.m.XXXXXXXXXX3XXXX2
History and Physical
* Final Report *
Result Type:
History and Physical
Date:XXXXXXXXXXXXXXXX3 15:45 CDT
Result Status:
Auth (Verified)'
Result Title:
H&P XXXXXXP.
Performed By:
A onXXXXXXXXXXXXXXXX3 15:53 CDT
Verified By:
A onXXXXXXXXXXXXXXXX3 15:53 CDT
Encounter info:XXXXXXXXXXXXXXXXXXXXXXXXXXXXt,XXXXXXXXXX3 -
* Final Report*
H&P
Patient:
MRN:
FIN:
Age:XX9 years Sex:XXXXXXe
DOB:
Associated Diagnoses: None
Author:
Admission Information
Date of Admission:XXXXXXXXXX3 .
Subjective:
Chief Complaint:XXXXXXXr,XXXXXXXXXXXXXaXXXXXXXXXc
History of Present Illness:
HISTORY OF PRESENT ILLNESS
XX9 year old HOMELESS AAF admitted for severeXXXXXXXXXs
-she was found wandering about in the store with trespassing order against her.
-she wasXXXXXXXXXXe in the emergency roomand threatening to kill the staff
-Talking without making any sense. She hadXXXXXXXXXXXXXXXs and was very tangential.
-she wasXXXXXXXXXXXXt with theXXXXXXXXXXXs.
--herXXXXXXXXXXXr in theXXXXXXXXXXXXXXXXXs 390 and she was given 18 units ofXXXXXXXn.
ASSOCIATED COMPLAINTS:
-XXXXXXXXXXXXXXs=DeniesXXH,XXX.
--VeryXXXXXXXXXXl andXXXXXXXXXc.
-XXXXXXXXXXXXXXXXXXs=None.
-XXXXXXXXXXXXXXXXXXXn=None.
-XXXXXXXXe-Without any change from baseline.
-Recent suddenXXXXXXXXXXXXXe=none.
XXXXXp=POOR
-Medication compliance at home=As per the report,homeXXXXXXXXXXXs are not taken as prescribed.
-XXXXn=Scale 0/10.
--Systemic complaint= noneXXU complaints=Denies anyXXXXXXXaXXXXXXXXXaXXXXXkXXXXn etc.
Printed by:

Printed onXXXXXXXXXX23 09:19 CDT
PDF Page 4
123
10:46:43 a.mXXXXXXXXXX2XXXX42
History and Physical
* Final Report *
XXGI complaints=No alarmsymptoms oXXXXXXXXXXXiXXXXXXna oXXXXXXXXXXXss reported.
XXXXXXXXXXXXal complaints=Denies anXXXXXXXXXXXXXon,unusuaXXXXXXXXhe,focaXXXXXXXXXXXXXXXXXXXXXsXXXXXXiXXXXXXXXXXXXas etc.
XXXXXXXXXne complaints=NXXXXXXXXXXXXXXXXXXXXXXXXce oXXXXXXXXXXXXes reported.XXXXXXXXXry complaints=NXXXXXXXXXXis,unusual nocturnaXXXXXgh oXXXXXXXXXXXss reported.
-Dermetologic complaints=No neXXXXsXXXXXXXXis oXXXXXXXXXXXXon reported.XXXXXXXXXXXXXXXal complaints=NXXXXXnXXXXXXXXXng, morninXXXXXXXXXss or decrease iXXXOM of thXXXXXXts reported.XXXXXal complaints=No history of anXXXKD reported.XXXXXXXXiXXXXXXXXXXiXXXXXXXXia oXXXXXXXXXXXXce reported.XXXXXXXXXXXXXXar complaints=Denies anXXXXXsXXXXinXXXXXXeXXXXXXXXXes oXXXND oXXXXXlXXXXXXXXXng reported.
Other Problems: AS PER HPL.
Allergy Profile:
Allergy LIST:
shrimXXXXXXXXXXon List:
Active ScheduleXXXXXXXXXXXns
aXXXXXXXXneXXXXXXXXXXne)
10 mg, TAB, PO, DailyXXXXXXXX23 11:13:00 CDXXXXXXXXXXXneXXXXXXXXXXXXXXXXXXXXXXXte)
100 mg, CAP, PO, BID (2 times a day), Other-Enter in Order CommentsXXXXXXXX23 11:15:00 CDT, Stop datXXXXXXXX23 9:00:00 CSXXXXXXXXXXXXXXXteXXXXXXXXXXXXXXXte)
325 mg. TAB, PO, DailyXXXXXXXX23 11:20:00 CDXXXXXXXXXXXne nasalXXXXXXXXXXXne nasal)
100 mcg, SPRAY, Nasal, DailyXXXXXXXX23 11:23:00 CDXXXXXXXXXXXolXXXXXXXXXXXXXXXXte)
100 mg, NJ, M, Q4WEEK (Every 4 weeks)XXXXXXXX23 7:18:00 CDXXXXXXXXXXXXXXXXneXXXXXXXXXXXXXXXXne)
50 Unit, INJ, Subcut, DailyXXXXXXXXXX21:00:00DXXXXXXXXXXXXXXroXXXXXXXXXXXXXXXro)
18 Unit, INJ, SubcutXXXXXAC (3 times a day before meals)XXXXXXXX23 10:00:00 CDXXXXXXXXXXilXXXXXXXXXXil)
10 mg. TAB, PO, DailyXXXXXXXX23 11:14:00 CDXXXXXXXXXINXXXXXXXXXIN)
1,000 mg, TAB, PO, BID (2 times a day)XXXXXXXX23 10:00:00 CDXXXXXXXXXXneXXXXXXXXXXne)
20 mg, TAB, PO, QHS (At bedtime)XXXXXXXX23 21:00:00 CDT
PRNAdministrations In Last 24 HourXXXXXXXXXXXXXenXXXXXXXXXXXXXen)
650 mg, TAB, PO, Q6H (Every 6 hours), PRXXXXinXXXXXXXX23 10:12:00 CDTXXXXXXXX23 10:12:00 CDXXXXXXXXXXamXXXXXXXXXam)
1 mg, TAB, PO, Q8H (Every 8 hours), PRN as needed foXXXXXXXtyXXXXXXXX23 1:22:00 CDT
Past Medical History:
HEALTH HISTORXXXXXXXar
PatienXXXXXXXXXXXXXXXXXus
PatienXXXXXXXXXXXXon
PatienXXXXXXXXXXXXXXXXXXXXXXXXer
PatienXXXTIXXXXXXXXXXXXXXXXXXXXXXXon)
Patient
Social History:
Social History:
Printed by:

Printed oXXXXXXXXXX023 09:19 CDT
PDF Page 5
123
10:47:09 a.XXXXXXXXXX0XXXX/42
History and Physical
* Final Report *
Education: High school graduate or GED
Preferred Language: English
Recent Travel: No recent travel
Signs of Abuse: XXXXXXXhol UXXXXXXXhol Use: NevXXXXXXXcco Use
Smoking Status: Current every day smokXXXXXXXcco cessation Information offered: Patient refuses InformatiXXXXXXXcco TypXXXXXXXXXXtes
Years of Use: 20
Tobacco Type: Cigarettes
Years of Use: 20
Tobacco use: Never smoked cigaretteXXXXXXXhol use: Never usXXXXXXXhol.
licit drug use: Never usXXXXXXXXXXXXXugs.
Living situation: Lives with family.
OccupatioXXXXXXXXXXyed.
Family History:
FAMILY HEALTH HISTORY
Unknow n.
Review of SysteXXXXXXXXXXXXXXnal: NegativXXXEye: Negative except as documented in history of present illnesXXXEXXXXoXXXXXuXXXXXXoXXXXXXXXive except as documented in history of present illnesXXXXXXXXXXXory: Negative except as documented in history of present illnesXXXXXXXXXXXXXXlar: Negative except as documented in history of present illnesXXXXXXXXXXXXXXXXnal: Negative except as documented in history of present illnesXXXXXXXXXXXXXary: Negative except as documented in history of present illnesXXXXXXXXXXXXXXXXXXXXXics: Negative except as documented in history of present illnesXXXXXXXXXine: Negative except as documented in history of present itlnesXXXXXXXXXXXgic: Negative except as documented in history of present illnesXXXXXXXXXXXXXXXtal: Negative except as documented in history of present illnesXXXXXXXXXXXXXary: Negative except as documented in history of present illnesXXXXXXXXXXgic: Negative except as documented in history of present illnesXXXXXXXXXXXric: Negative except as documented in history of present illness.
ROS reviewed as documented in chaXXXXXXXXXXXXXXXXXXXXiXX
VS/MeasuremenXXXXXXALXX
BP: 136/XXXXXlse: 1XXXXemp: 97XXXXeXXXXate: XXXXmax: 97.6 Wt(kg): 90.71
Printed by:

Printed XXXXXXXXXX2023 09:19 CDT
PDF Page 6
123
10:47:31 aXXXXXXXXXX2XXXX8/42
History and Physical
* Final ReporXXXXXXXXXXcore:XXX Sat:XXXXXXXX8/23 01:57
02 Status: Roomair XX%
Wt(kg): 90XXXXXXight daXXXXXXXX8/23
Wt(kg):
90XXXXXXight daXXXXXXXX8/23
Wt(kg): 90XXXXXXight daXXXXXXXX8XXXXXXXerXXXXXlert XXXXXXXXnted, No acXXXXXXXXreXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXmits.
Ambulation status: WXXXXXXXXXXXgaXXXXXXXXXXanXXXXXbese.
Behavior: Within normal limiXXXXXXXXXtion: Within normal limiXXXXSkXXXXXXXXXXXXXXXXXXXXmiXXXXXXXXXXXXXXXXXXXXciXXXXXXXXXXXtrXXXXXXXXXXXtiXXXXXXXXXXXXXXXXXXXXXXXXXfeXXXXXXXXXXXXidal,XXXXXXXXXXXXXvior.
Thought proceXXXXXXXXusXXXXXXXXXXXXibXXX
EXXXXXXpils XXXXXquXXXXXound XXXXXXXXXXXXXXXXXigXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXtaXXXXXXrXXXXXXXXXXXtiXXXXXXXXXXXXXXXXngXXXXHEXXXXXXXXXXXXXalXXXXXXXXXXXXXXriXXXXXXXXXXXcosaXXXXXoist,XXXXXXXXXXgXXXXXXXXheXXXXXXXXXXnXXXXXXtent,XXXXXiXXXXXXXXXXneXXXXNeXXXXXXppXXXXXXXXXXnder,XXXXXXXoXXXXXruit,XXXXXXXXXXXXXXXXXXXXXXXXXtion,XXXXXXXXXXXXXXXathy,XXXXXXXXXXXgaXXXXXXXXXXXtoXXXXXungs XXXXXXXXXXXXXXXXXXXXXtiXXXXXXXXXXXXXXXXXXXXXXXXXXXXorXXXXXXXXXXXXXXXXXXXXXXXqual, SymmetriXXXXXXXXXXXXXXXXXXXXsion,XXXXXXXXXXwXXXXXXXXXXneXXXXXXXXXXXXXXulXXXXXXXXXXXraXXXXXXXXXXXXXXythm,XXXXXXrmur,XXXXXXllXXXXXXXXXXXXXXXXXXXXXXXXXXXsion, GXXXXXXlses equalXXXXXXXXXXXXXXXties,XXXXXdeXXXXXXXXXXXXXXXXinXXXXSoXXXXXXXXXXndXXXXXXXXXXXXXndXXXXXXXXXXXXXXXXXunds,XXXXXXXXXXXXgaXXXXXXXXXXXXXXXetXXXXXXXXXXXXXXXXXXXXXXtiXXXXXXXXXXXXXXXngth,XXXXXXXXXXness,XXXXXXXXling,XXXXXXXXXmiXXXXXXXXXXXgaXXXXXXXXXXXXXtaXXXXWaXXX DXXXXXoist,XXXXXXllor,XXXXrash, RiXXXXfoot there is a diabeXXXXfXXXXXlcer without XXXXXXXXXXitisXXXXXXXXnaXXXXXXXXXXogXXXXXXXXXXXXical exam:
Aw XXXXXlXXXXXXXXnted to time place and person and situatXXXXXXeeXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXiate. There isXXXXXXXasiaXXXXXXXXXXhrXXXXXXXXXXXXXXXXXXXXXXXXXedge
Normal recent and remote memory
DTR2XXXXXXXXXXTAXXXXXXXXXXXXXXXXXXXXXoing bilateralXXXXXXXXXXXXXXsoXXXXXXXXXXXXXXXXXXXXXtion, No foXXXXXXXXciXXXXXXXXXXXXXXrves:XXXXXptXXXXXXtacXX,XXIXXV/XXXXXXXXXXoXXXXXXXXXlXXXXXXXXceXXXXXXtaXXXXXXpXXXXXquXXXXXound XXXXXXXXXXXXXXXXXighX),XXXXXXXXXXinal
(BilateralXXXXXXtact, MotXXXXXoXXXXXXXning (IntacXXXXXXXXngth (IntactXXXXXXXXXXXXXXXXXXXXXXXXouch (NormaXXXXXXXXXXXXXXXXXpain (NormalXXX VXXXXXXcial
(BilaterXXXXXXXXhXXXXXXXnkXXXXXXXXXXXsiXXXXXXXXXXXXXXXXXtiXXXXXmile, intacXXXXVIII Acoustic (IntacX), XXXXXXXXXXXXXXXXXgXXXXXagXXXXXvula
elevation (Within normal limits). SymmetXXXXXXXXXXXlate elevatioXXXXXXXXXXXXXXXXXXXtaXXXXXXXXXXXXXXXXXXXXXXXXXXXXngXXXXXXXXXzlus strengtXXX XIL
HypoglossXXXXXXeech (clear and coherenXXXXXXngue strength (protruded in midline withXXXXXXemorXXXXXXXXXXXXXtionXXXXXXXXXXXtrXXXXXXXXXXXtiXXXXXXXXXXXXXXXXXXXXXXXXXfeXXXXXXands: BilaterXXXXXXXXXXXXXXlaXXXXXXXXXXXXXlaXXXXXXXXXXXXXXXXXXXlaXXXXXXXXXXXXXXXXXanXXXXXXXXXXXXXXXXXXXXmits.
Objective
Lab Results:
Printed by:

PrintedXXXXXXXXXX/2023 09:19 CDT
PDF Page 7
123
10:48:00 XXXXXXXXXX-XXXX
9/42
History and Physical
* Final RepoXXXXXXXXXXATORY RESUXXXXXXXXXXXe POCXXXXXXXX18/23 1XXXX
XXXc POC GLE
2XXXXXXXXXXXe POCXXXXXXXX18/23 0XXXX
Gluc POC GLE
3XXXXXXXXXXATORY RESUXXXXXMicro ResuXXXXXXXXXXXXXXXXXXXXUDIES RESULTED WITHIN THE LAST 2 DAYS.
See LAB tab for older resultsXXXXXXXXtures resulted In the last 2 days..
Radiology results:
COMPLXXXXXXXXXXXXXXXXXXXXXXXXXUDIES:
No Imaging Results in the last 36 hours.
Diagnostic Tests: AllXXXXXXXXXXXXXXXXXXXXX workXXXXXXXXXXXXXXXXorkup done at the referring facility has been reviewed..
Documentation review: Reviewed old records, Reviewed records XXom EXXXXXXXXXXXXXXXXXXXpital..
Review /Management
Diagnostic Impression:
Diagnosis XXXXXXXxXXXXXXXXXXXXXXXXoXXXXXXXXaXXXXXXXXXXXXnXXXXXXXXXXXXXrXXXXXXXXXXXXXXXXXaXXXXXXXXXXXXXXXXXlXXXXXXXXXXXXXXuXXXXXXXXXhosis
Printed by:

PrinteXXXXXXXXXX4/2023 09:19 CDT
PDF Page 8
123
10:48:15XXXXXXXXXX4XXXXX
10/42
History and Physical
* Final Report *
Include Orders
Consults:
Consult Physician (Order ProcessXXXXXXXXXX8/2023 15:53 CDT, DIAXXXXCXXXXX ULCER, Routine,
Not
Done
Include Orders
Consults:
Consult Wound Ostomy Continence Nurse (WOCN) (Order ProcessXXXXXXXXXX8/2023 15:53 CDT, Routine
Plan
PEXXXXXXXXXXXXXXXX TXXXS:
TSH
OrXXXXXXXXXXXXXXin A1c
OrXXXXXXXXXXXXlXXXXXXXXXXXXRandom
OrXXXXXXXXXXX Panel
Ordered
PDF PXXXXXXXXXXXXXXyXXXXX Urine
Ordered
PEXXXXXXXXXXXXXXXXXXXXXXXXXTUDIES:
ORDERS WITHIN THE LAST HOUR
SHAHZAD MD, MUHAMMADA
ASSESSMENT & PLAN:-
--XXXCK FLP IF NOT DONE IN 3 MONTHS.RXXXXXXXXXE MEDS.DIETRAY COUNSELING DONE
--MOXXTOR BP.LIFE STYLE MODIFICATIONS EXPLAINED TO THEPATIENT,
--XXXXXXXXXXX LEVEL IF NOT DONE IN 3 MXXXXXXXXA DIET.MOXXXXXXXXXXXXSUGARS.DIETARY COUNSELING DONE SXXXXXXXXXXXXXXXXXXXONTROL SHOULD BE EXERCISED
-OBTAIN PODIATRY CONSULT FOXXXXE XXXXXXXXXXXXXXXXXXXXXXXXXXXSELING DXXXXXXXXXXXXXXXCATION USE LIMITS SET WITH THEPATIENT AND AGREED UPONPATIENT VERBALISED UNDERSTANDING
--SLEEP LOG TO BE INITIATEXXXXXXXXXXXXXXXXXXXXXXXXDRINKS AND COFFEE
--XXXXXXXXX LXXXXXXXXXXL CARE OXXXXEXXXXX WOUND
-INHALERS AS NEEDED
-RXXXXXXXXXXXXXXXXXNSIVES. PARAMETERS PLACEXXXXXXXXXXXXXXXXXXXXXXXXXCATION HOLDING
--THEPATIENT IS HOMELESS THE SOCIAL WORKER SHOULD BE TAKING CARE OF THAT ON DISCHARGE
Printed by:

PrintXXXXXXXXXX24/2023 09:19 CDT
PDF Page 10
123
10:48:3XXXXXXXXXX2XXXXX3
11/42
History and Physical
* Final RepoXXX*
--CBC IS ACCEPTABLE.FOLLOW AS OUTPT.
--MEDICATION COMPLIANCE COUNSELING DONE
--COXXXXXXXXXXXXXXXCIFEROL.
-MXXITOR HR AND THE RHYTHM.
--WEIGHT LOSS ADVISED.
--PSYCH MANAGEMENT & MED RECONCILIATION AS PER PSYCHIATRIC SERVICES.
--THXXXXXXXXXXICATION HISTORY HAS BEEN REVIEWED AND RECONCILED AXXXXXXXXXXXCATIONS ADJUSTED AS NEEDED.
-AFTER DISCHARGE FOLLOWUP WITH ME OR PCP WITHIN 3-4 DAYS.
--ADVISED TO REPORT TO THE PCP OF DEVELOPMENT OF AXXXXXXXXYMPTOMS XXXXXXXXXXXXEFFECTS OF THE MEDICINE
IMMEDIATELY UPON NOTICING IT.
Signature Line
[Electronically Signed ByXXXXXXXXXX18/2023 03:53 PM
Completed Action List:
* PerformXXXXXXXXXXXXXXXX8, 2023 15:53 CDT
* SignXXXXXXXXXXXXXXXX8, 2023 15:53 CDT
* VERIFYXXXXXXXXXXXXXXXX8, 2023 15:53 CDT
Printed by:
PrintXXXXXXXXXX/24/2023 09:19 CDT
PDF Page 11
123
10:48:XXXXXXXXXX-XXXXX23
12/42
PDF Page 12
123
10:48:XXXXXXXXXX-XXXXX2XXXXXXXXXXXXXXXXXXXXXXaluation
* Final Report *
Result Type:
Psychiatric EvaluatioXXXXXXXXXXXXXXXX19, 2023 08:30 CDT
Result Status:
Auth (Verified)
ResultXXXXXXXXXXXXXXXXXXXXXXaluation
PerformedXXXXXXXXXXXXXXXX19, 2023 08:03 CDT
VerifiedXXXXXXXXXXXXXXXX19, 2023 10:14 CDT
EncounteXXXXXXXX50036288, GLE, Behavioral HealthXXXXXXXXXX/18/2023-
Contributor system:
GLE MMODAL
* Final Report*
Psychiatric EvaluatioXXXXXXXXXX/18/2023
HISTORY OF PRESENT IXXNESS:
39-yXXXXXXd female born on
was admiXXXXXon 10/18, XXXXXon 10/18 on site. This
patient caXXXXXXXXXXXXXXXXXXXHospital, was wandering trespassing at best by, making verbal
threats at the hospital. She made verbal threats toward the staff, threatened to leXXe
the XXXXXXXXagitated, requiredXXXXXXXXXXdication inXXXXXXg AtiXXXXXXX
Zyprexa
IM. The patient does have a legal guardian.
PAST MEDICAL HISTORY:
IXXXXXXXXdiXXXXXXXXXXXXrtension, XXXXXXXXXXXXXophrenia. The patient has aXXXXXer
wound
on
thXXXight leXXXLeft legXXXXXXX bXXXtoe. UDS was neXXXXXXXXXXXXXXncy test was
negative.
LEGAL XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXunXXXXXXXXXXXXXL STATUS:
The patiXXXXXXXXXXXXXX dresXXXXXXX groomed. She was XXXXXXXXXXXXXXXXXXXbeXXXXXXXXXXXXXXXXd XXXXXXXXXXXXXXXundaries. Intelligence and fund of knowledge aXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXraXXXXXXXXXXXXXXXXXXXXXXXXXXXXcoXXXXXX. Speech was tangential and
loud. Denied iXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXideation. XXXXXXXXorienXXXXXXXXXXXXXXXXXXXXXXXXXXXXat vague for remote and recent events.
DIAXXXXXXXXXXXXXXXXdisorder, mixed.
REASON FOR ADMISSION:
SEVERITY OF ILLNESS CRITXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX threats.
2.
Marked regression or intensification of signXXXXXXXXprobXXXXXXXXsymptoms.
Printed by:

PriXXXXXXXXXX0/24/2023 09:19 CDT
PDF Page 13
123
10:49XXXXXXXXXX0XXXXX0XXXXXXXXXXXXXXXXXXXXXXvaluation
* Final Report *
3XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXform XXXXXXXXXXXXXXXXXXXto comXXXXXXXXXXXXXXXXXXXXXXedication or other prescribed treatment.
5.
Clinically dXXXXXXXXXXXstability of the patXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXty safety.
INTENSITY OF SERVICE CRITXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXtreatment in an outpatient or other less restrictive milieu
sXXXXXXXX symptoms are worsened or course of illness has deteriorXXXXXXXXXXXXXXXXXXXXXXXedication administration requires monitoring available only in an
inpatient setting.
3.
Diagnostic evaluation or treatment planning requires 24-hour-per-day skilled
observations in an inpatient setting.
SHORT-TERM GOAL:
Admit to the locked psychiatric unit. Prevent self-harm.
LONG-TERM GOAL:
Stabilize and return back to the community.
Her projected length of stay is 4 to 5 days.XXXXtine labs were ordered. They sXXXXXXXXXXXXXXXXd XXXXXXXXXXXC glucose of 217 and XXXXXXX. Shahzad was assigned to do the H and P
and medical management. Projected length of stay is 4 to 5 days.
DISCHARGE PLAN:
XXXXXXXXXXXXXplacemXXXXXXXX/23812791/XXXXXXXXXX0/19/2023 08:0XXXXXXXXXX0/19/2023 08:30:39
Job #:
Signature Line
[Electronically Signed BXXXXXXXXXX0/19/2023 10:14 AM
Completed Action List:
* PerfoXXXXXXXXXXXXXXXX 19, 2023 08:03 CDT
* TranscriXXXXXXXXXXXXXXXX 19, 2023 08:30 CDT
* SiXXXXXXXXXXXXXXXX 19, 2023 10:14 CDTRequXXXXXXXXXXXXXXXX 19,
2023 08:33 CDT
Printed by:

PrXXXXXXXXXX10/24/2023 09:19 CDT
PDF Page 14
123
10:4XXXXXXXXXX1XXXXX2XXXXXXXXXXXXXXXXXXXXXXEvaluation
* Final Report *
* VERXXXXXXXXXXXXXXXXr 19, 2023 10:14 CDT
Printed by:

PXXXXXXXXXX
10/24/2023 09:19 CDT
PDF Page 15
123
10:XXXXXXXXXX
XXXXX-2023
16/42
PDF Page 16
123
10:XXXXXXXXXX
XXXXX-2023
17/42
Flowsheet Print Request
Patient:
Printed by:
MRN:
DXXXXXXXXXX 10/23/20XXXXXXXXXX 10/25/2023 09:19
PXXXXXXXXXX 10/24/XXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXXXMXXXXXXXXXX
XXXXXXXXXX
10/24/2023
09:00
07:30
07:00
21:00
17:00XXXXXXXXXX
amLODIPine
10 mg
10 mg, TAB, XXXXXXXXy, 10/18/23 11:13:00 CDT
Last given
At home, patient XXXXXXXXXX medication wiXXXXXXXXXX
10/24/2023XXXXXXXXXXXXXXXXXXXXX
benzocainXXXXXXcal (Orajel)
1 APP
1 APP
1 APP
1 APP, GEL TOP, 4 tiXXXXXXXXy, 10/23/23 17:00:00 Last given:
Last given:
Last given:
CDT
1 APP @
1 AXXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXX
10/24/2023
08:29 CDT
08:29 CDTXXXXXXXXXX
benzocaiXXXXXXXXXl
cadexomer lodinXXXXXXXXXXXXXXXXomer Iodine
0.9, GEL, TXXXXXXXXy, 10/21/23 9:00:00 CDT
Lastgiven
CXXXXXX the wounds with NS, pat dry, apply loXXXXXXXXXX
10/22/2023XXXXXXXXXXXXXXXXomer-iodine topicaXXXXXXXXXXXdoXXXXXXXXXXXXXXXXXXXXXXXmonohydrate)
Last given:
100 mg, CAP, PO, BID (2 times a day), Other-Enter
100 mg @
in OrderXXXXXXXXs, 10/18/23 11:15:00XXXXXXXXXX
10/24XXXXXXXXte 11/28/23 9:00:00 CST
08:03XXXXXXXXXXXdoxycyclXXXXXXXXXXXXXXXous sulfate
Last given:
325 mg, TAB, XXXXXXXXy, 10/18/23 11:20:00 CDXXXXXXXXXX
10/24/2023XXXXXXXXXXXXXXXoXXXXXXXXXXXfXXXXXasone nasal
100 mcg
100 mcg, SPRAY, NasXXXXXXXXy, 10/18/23 11:23:00
Last given
CDTXXXXXXXXXX
10/24/2023XXXXXXXXXXXXXXXXXasonXXXXXXXXXXXhaXXXXXXXXXXXXXXXXl Decanoate)
100 mg, INJ, IM, Q4WEEK (EveryXXXXXXXX),
10/18/23 7:18:00 CDT
At home. patient XXXXXXXXXX medicatioXXXXXXXXXXXhaloperidol
Richmond Agitation-Sedation ScXXXXXXXXXXXXXXXXratory Rate
/8
10XXXXXXXXXXXhaXXXXXXdol (Haldol)
Last given:
Last given:
10 mg, TAB, PO, BID (2 timXXXXXXXX). 10/22/23
10 mg @
10 mg; @
9XXXXXXXXXX
XXXXXXXXXX
10/24/2023
08.03 CDT
06:03 CDT:
haloperidol
Richmond Agitation-Sedation ScXXXXXXXXXXXXXXXXratory Rate

PDF Page 17
123
10XXXXXXXXXX.XXXXX4-2023
18/42
Flowsheet Print Request
Patient:
Printed by:
MRN:
XXXXXXXXXX: 10/23/2XXXXXXXXXX1 10/25/2023 09:19
XXXXXXXXXX: 10/24XXXXXXXXXX9XXXXXXXXXX3XXXXXXXXXX3XXXXXXXXXX3XXXXXXXXXX3XXXXXXXXXXX
Medications
09:00
07:30
07:00
21:00
17XXXXXXXXXXXXXXXXlin glargine
Last given:
50 Unit, INJ, SubXXXXXXXXly, 10/18/23 21:00:00 CDT
50 Unit
At home, patientXXXXXXXXXXg mediXXXXXXXXXXh
10/23/202XXXXXXXXXXXXXXXXlin glargine
Blood Glucose, MAR
2nd Clinician Verification Before AdmiXXXXXXXXXXXXXXsulin lispro
Last given:
18 Unit, IXXXXXubcut, TIDAC (3 times a day before
18 UniXXXXXXXXs), 10/18/23 1XXXXXXXXXXT
10/23/2023
At home. patientXXXXXXXXXXg medication with
12:13 CDT
insulin lispro
Blood Glucose, MAR
2nd Clinician Verification BXXXXXXXXXXn
lisinopril
10 mg, TAB,XXXXXXXXly, 10/18/23 11:14:00 CDT
At home, patientXXXXXXXXXXg medication withXXXXXXXXXXT
lisinoprXXXXXXXXXmg
metFORMIN
Last given:
1,000 mg, TAB, PO, BID (2 tiXXXXXXXXy), 10/18/23
1000 mg @
1XXXXXXXXXXT
10/21/2023
At home. natientXXXXXXXXXXg medication witXXXXXXXXXDXXXXXXXXXXN
OLANZapine
20 mg
20 mg, TAB, PO, QHS (AXXXXXXXXe), 10/18/23
Last given:
21:00:00 CDT
20 mg
At home, patientXXXXXXXXXXg mediXXXXXXXXXXh
10/23/202XXXXXXXXXXT
olanzapine
Richmond Agitation-Sedation SXXXXXXXXXXXXXXXXiratory RatXXXXXXXXXXXXXcetaminophen
650 mg, TAB, PO, Q6H (Every 6 XXXXs)XXXXXXXXin,
10/18/23 10XXXXXXXXDT, 10/18/23 10:12:00 CDT
At home, patientXXXXXXXXXXg medication with -
acetaminophen
XXXXtion of Pain
Pain Site
Acute Paln XXXXe
AcutXXXXXXXXXXXXXXXXXXc Pain ScXXXXChronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-Sedation SXXXXXXXXXXXXXXXXiratory Rate
Med Responses

PDF Page 18
123
1XXXXXXXXXXmXXXXX24-2023
19/42
Flowsheet Print Request
Patient:
Printed by:
MRN:XXXXXXXXXXe: 10/23/XXXXXXXXXX - 10/25/2023 09:19XXXXXXXXXXn: 10/2XXXXXXXXXXX9XXXXXXXXXXnXXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX23
10/24/2023
09:00
07:30
07:00
21:XXXXXXXXXPRXXXXXXXXXol (albuterol inhaler)
180 mcg, INHALER, Inhalation, Q4H (Every 4XXXXXXXXXXXXXXXXXXXesXXXXXXXXath, 10/18/23
XXXXXXXXXCDT
aXXXXXXXXXXXN
benztropine
1 mg, INJ, IM, Q8H (Every 8 hours), PRN Other (sXXXXXXXXnt), 10/18/23 XXXXXXXXCDT, 10/18/23 1:2XXXXXXXXXPRN StiffieXXXXXXXXXXXa
benXXXXXXXXXXXXXXXXXiuXXXXrbonate (Tums 500)
1,250 mg, CHEW TAB, Chewed, TID (3 timesXXXXXXXXXPRXXXXXXXXsia. 10/18/23 XXXXXXXXXXXXXXXXXium cXXXXXXXX
PXXXXXXusate (Colace)
100 mg, CAP, PO, BID (2 timesXXXXXXXXXXXX
CXXXXXXXXion, 10/18/23 1XXXXXXXXCDT, 10/18/23
XXXXXXXX CDT
XXXXXXXXXXXNXXXXXicXXXXXXXXXXX (fluticasone 50 mcg/inh nas...
50 mcg, 1 Spray,XXXXXY, Both NaresXXXXXXXXXXRNXXXXXXXXion, 10/18/23 10:13:00 CDT
At home. patienXXXXXXXXXXng medXXXXXXXXXXXh
fluticasoXXXXXXXXXXXN
haloperidol
5 mg, TAB, PO, Q8H (Every 8XXXXXXXXXPRXXXXXXXXion,
10/18/23XXXXXXXXXXXT
haloperidol
Richmond Agitation-Sedation Scale (RASS)
Respiratory Rate
Med RXXXXXXXXXXXN
haloperidol
10 mg, INJ, IM, Q3H (Every 3XXXXXXXXXPRXXXXXXXXion, 10/18/23 1:22:00 CXXXXXXXXXXis medication ONLY if patient canXXXXXXXXXXX.
haloperidol
Richmond Agitation-Sedation XXXXXXXXXXXXXXXXpiratory Rate
Med RXXXXXXXXXPRXXXXXXrofen (Motrin)
400 mg, TAB, PO, Q8H (Every 8XXXXrs), PRNXXXXXXXXild, 10/23/23 1XXXXXXXXCDT, 10/23/23 XXXXXXXXXCDT
ibuprofen

PDF Page 19
123
XXXXXXXXXX.XXXXX-24-2023
20/42
Flowsheet Print Request
Patient:
Printed by:
MRNXXXXXXXXXXge: 10/23XXXXXXXXXX9 - 10/25/2023 09:1XXXXXXXXXXon: 10/XXXXXXXXXXX1XXXXXXXXXXoXXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX023
10/24/2023
09:00
07:30
07:00
21:00
17:0XXXXcation of Pain
Pain Site
Acute PaiXXXXore
Acute PainXXXXl
Chronic Pain XXXXe
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-SedationXXXXXXXXXXXXXXXXspiratory Rate
Med ReXXXXXXXXXXPRXXXXXXXXXXXe (Imodium A-D)
4 mg, CAP, PO, Q6H (Every 6 hours), PRN XXXXXXXXXXXorXXXXXXXXtool, 10/18/23 XXXXXXXX GDT,
10/18/23XXXXXXXXXXCDT
loperXXXXXXXXX
PRN
LORazepam
1 mg, INJ, IM, Q6H (Every 6 hours), PRN XXXXXXXedXXXXXXXXiety, 10/18/23 1:22:00 XXXXXXXXXXhis medication ONLY if patient XXXXXXXXXler.
LORazepam
Richmond Agitation-Sedation Scale (RASS)
Respiratory Rate
Med ResXXXXXXXXX
PRN
LORazepam
1 mg, TAB, PO, Q8H (Every 8 hours), PRN XXXXXXXedXXXXXXXXiety, 10/18/2XXXXXXXXX CDT
LORazepam
Richmond Agitation-Sedation Scale (RASS)
Respiratory Rate
Med ReXXXXXXXXXXXXXXXXXXXsium hydroxide
2.4 GM, SUSP, PXXXXXXXXXXXXN XXXXXXXXtion,
10/18/23 XXXXXXXXXXXXXXXXlkXXXXXXXXXXXXXXXXXXXsium hydroxide
Med XXXXXXXXXXXRNXXXXXXXXXXon (Zofran ODT)
4 mg, DIS Tablet, PO, Q8H (Every XXXXXXXXXXXXXXXauXXXXXXXXting, 10/18/23 XXXXXXXX CDT,
10/18/23 10-14-00 CDT
ondansetron
Med Responses

PDF Page 20
123XXXXXXXXXXaXXXXX0-24-2023
21/42
Flowsheet Print Request
Patient:
Printed by
MRXXXXXXXXXXnge: 10/2XXXXXXXXXX19 - 10/25/2023 09:XXXXXXXXXX on: 10XXXXXXXXXX9XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXXX023
Medications
16:30 16:00 13:00 12:00 0XXXXXXXXXXuled
amLODIPine
10 mg, TXXXXXXXXDaily, 10/18/23 11:13:00 CDT
At home, patiXXXXXXXXXXking mXXXXXXXXXXwXXXXXXXXXXpine
benzoXXXXXXtopical (Orajel)
1 APP, GEL, TOP, XXXXXXXXa day, 10/23/2XXXXXXXXXX
CDT
10/24/2XXXXXXXXXXCDT:
benzXXXXXXXXXXXXXXXXadexomer IXXXXXXXXXXXXXXXXadexomer Iodine
0.9, GEXXXXXXXXDaily, 10/21/23 9:00:00 CXXXXXXanse the wounds with NS, pat dryXXXXXXXXXXXXXXXXadexomer-ioXXXXXXXXXXXl
XXXXXXXXXXXXXXXXXXXXXXXine monohydrate)
100 mg, CAP, PO, BID (2 times a day), Other-Enter
in OXXXXXXXXments, 10/18/23 11:15:00 XXXXXXXXp
date 11/28/XXXXXXXXXXXCSTXXXXXXXXXXXXXXXferrous sulfate
325 mg, TXXXXXXXXDaily, 10/18/2XXXXXXXXXXXXXXXfXXXXXXXXXXXate
fluticasone nasal
100 mcg, SPRAY,XXXXXXXXDaily, 10/18/2XXXXXXXXXXXXXXXXXXXXXXXXXXXXXsaXXXXXXXXXXXXXXXXaldol Decanoate)
100 mg, INJ, IM, Q4WEEK (EXXXXXXXXeeks),
10/18/23 7:18:00 CDT
--- At home. patiXXXXXXXXXXking medication with
haloperidol
Richmond Agitation-SedatioXXXXXXXXXXXXXXXXespiXXXXXXXXXXe
1XXXXXXperido! (Haldol)
10 mg, TAB, PO, BID (2XXXXXXXX day). 10/22/23
9:00:00 CDT
haloperidol
Richmond Agitation-SedatioXXXXXXXXXXXXXXXXespiratory Rate

PDF Page 21
12XXXXXXXXXX XXXXX10-24-2023
22/42
Flowsheet Print Request
Patient
Printed by:
XXXXXXXXXXange: 10/XXXXXXXXXX:19 - 10/25/2023 09XXXXXXXXXXd on: 1XXXXXXXXXXX9XXXXXXXXXXtXXXXXXXXXX/XXXXXXXXXX/XXXXXXXXXX/XXXXXXXXXX/2023
10/24/2023
16:30
16:00
13:0XXXXXXXXXXXXXXXXinsulin glargine
50 Unit, INJ,XXXXXXXX Daily, 10/18/23 21:00:00 CDT
At home, patXXXXXXXXXXaking XXXXXXXXXXXXXXXXinsulin glargineXXXXXXXGlucose, MAR
2nd Clinician Verification Before Admin
R
XXXXXXXXXXXXXXt
Insulin lispro
Last given:
Last given:
18 Unit, INJ, Subcut, TIDAC (3 times a day before
18 Unit @
XXXXXXXXmeals), 10/18/XXXXXXXXXX0XXXXXXXXXX/2023
10/23/2023
At home. patXXXXXXXXXXaking medication with
12:1XXXXXXXXXXXXXXT
insulin lispro
Blood Glucose, MAR
2nd Clinician VerificatiXXXXXXXXXXAdmin
lisinopril
10 mg, XXXXXXXX Daily, 10/18/23 11:14:00 CDT
At home, patXXXXXXXXXXaking XXXXXXXXXXXXXXXXXXXXXXpril
B
metFORMIN
1,000 mg, TAB, PO, BID (XXXXXXXXa day), 10/18/23
10:00:00 CDT
At home. patXXXXXXXXXXaking XXXXXXXXXnXXXXXXXXXXORMIN
OLANZapine
20mg, TAB, PO, QHXXXXXXXXdtime), 10/18/23
21:00:00 CDT
At home, patXXXXXXXXXXaking XXXXXXXXXX with
olanzapine
Richmond Agitation-SedatiXXXXXXXXXXXXXXXXRespiratory Rate
PRXXXXXXXXXXXXXmg
acetaminophen
Last given:
650 mg. TAB, PO, Q6H (EverXXXXhours), PRNXXXXXXXX50 mg.@
10/18/2XXXXXXXX00 CDT, 10/18/XXXXXXXXXX0 CDT
10/23/2023
At home, patXXXXXXXXXXaking medicationXXXXXXXXXXXXXDT
acetaminopXXXXLocation of Pain
XXXX Site
Acute PXXXXScore
Acute Pain Goal
Chronic Pain Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-SedatiXXXXXXXXXXXXXXXXRespiratory Rate
Med Responses

PDF Page XXXXXXXXXX9 a.m.
10-24-2023
23/42
123
Flowsheet Print Request
PrintedXXXXXXXXXXRange: 10XXXXXXXXXX9:19 - 10/25/2023 0XXXXXXXXXXed on: XXXXXXXXXXX0XXXXXXXXXXaXXXXXXXXXX4XXXXXXXXXX4XXXXXXXXXX4XXXXXXXXXX4/2023
10/24/2023
16:30
16:00
13:00
12:00
PDF Page 23
0XXXXXXXXX18XXXXXXXXXuterol (albuterol inhaler)
Not given within
180 mcg, INHALER, Inhalation, Q4H (Every 4
5 dXXXXXXXXXXXXXXXXXXXorXXXXXXXX Breath, 10/18XXXXXXXXX:00 CDT
alXXXXXXXXXXX
1 mg
benztropine
Last given:
1 mg, INJ, IM, Q8H (Every 8 hours), PRN Other (seXXXXXXXXomment), 10/18XXXXXXXX:00 CDT, XXXXXXXXXX:22:00
10/22/2023
CXXXXXXXXXCDT
PRN StiXXXXXXXXXXXhesia
benztropXXXXXXXXXXXXXXXXXcaXXXXm carbonate (Tums 500)
Not given within
1,250 mg, CHEW TAB, Chewed, TID (3 times a dXXXXXXXXXysXXXXXXXXspensia. 10/18XXXXXXXXXXXXXXXXXcalcium carbXXXXXXXXN
XXXXXX
docusate (Colace)
Not given within
100 mg, CAP, PO, BID (2 times a dXXXXXXXXXXXXayXXXXXXXXipation, 10/18/XXXXXXXX:00 CDT, 10/18XXXXXXXX3-00 CDT
docXXXXXXXXXXX0 mcg
flXXXXXXXXXXXasal (fluticasone 50 mcg/inh nas...
Last given:
50 mcg, 1 SpXXXXXSPRAY, Both Nares, DaiXXXXXXXXXX mXXXXXXXXgestion, 10/18XXXXXXXXXX00 CDT
10/20/2023
At home, paXXXXXXXXXXtaking medicatioXXXXXXXXXXX8XXXXXfluticasone nXXXXXXXXXXX
5 mg
haloperidol
Last given:
5 mg, TAB, PO, Q8H (EveXXXXXXXXXs), PRN AXXXXXXXX,
5 mg @
10/1XXXXXXXXXX00 CDT
10/2XXXXXXXXXXX8 CDT
haloperidol
Richmond Agitation-SedatXXXXXXXXXXXXXXXX
Respiratory Rate
Med ResXXXXXXXXXXX10 mg
haloperidol
Last given:
10 mg, INJ, IM, Q3H (Every 3 houXXXXXXXXX10XXXXXXXXitation, 10/1XXXXXXXXXX00 CDT
10/2XXXXXXXXXXe this medication ONLY if patient cannot toXXXXXXXXXXX6 CDT
haloperidol
Richmond Agitation-Sedation Scale (RASS)
Respiratory Rate
Med RespXXXXXXXXX
4XXXXXXibuprofen (Motrin)
Not given within
400 mg. TAB, PO, Q8H (EveXXXX hours), PRN PaiXXXXXXXXs,
Mild, 10/23/XXXXXXXX:00 CDT, 10/23XXXXXXXXX:00
CDT
ibuprofen

PDF Page 24
XXXXXXXXXX41 a.m.
10-24-2023
24/42
Flowsheet Print Request
Patien
Printed by:XXXXXXXXXX Range: 1XXXXXXXXXX09:19 - 10/25/2023 XXXXXXXXXXted on:XXXXXXXXXX3XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXXX4/2023
Medications
16:30
16:00
13:00
12:00
09:19XXXXation of PaiXXXXin Site
AcuteXXXXn ScorXXXXXXXXXXXXXXXXXXChronic PXXXXScore
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-SedaXXXXXXXXXXXXXXXX)
Respiratory Rate
Med RXXXXXXXXXXRNXXXXXXXXXXXamide (Imodium A-D)
Not given within
4 mg, CAP, PO, Q6H (Every 6 hours), PRN as
5XXXXXXXXXXXedXXXXXXXXse stool, 10/18XXXXXXXX3:00 CDT,
10/1XXXXXXXXXX:00 CDT
lopeXXXXXXXXXPRN
1 mg
LORazepam
Last given:
1 mg, INJ, IM, Q6H (Every 6 hours), PRN as XXXXXXX1 XXXXXXXX anxiety, 10/XXXXXXXXXX:00 CDT
10/XXXXXXXXXXve this medication ONLY If patient cannot XXXXXXXXX1:36 CDT
LORazepam
Richmond Agitation-SedaXXXXXXXXXXXXXXXX)
Respiratory Rate
Med ResXXXXXXXXXPRN
1 mg
LORazepam
Last given:
1 mg, TAB, PO, Q8H (Every 8 hours), PRN as
XXXXXXXneXXXXXXXX anxiety. 10/XXXXXXXXXX:00 CDT
10/XXXXXXXXX0:52 CDT
LORazepam
Richmond Agitation-SedaXXXXXXXXXXXXXXXX)
Respiratory Rate
Med RespoXXXXXXXXXXXXXXXXXXXagnesium hydroxide
Not given within
2.4 GM, SUSXXXXXXXXXXXX, PRN ConsXXXXXXXX,
5 days.
10/18XXXXXXXXXXXXXXXX (XXXXXXXXXXXXXXXXXXXagnesium hydroxide
Med RXXXXXXXXXXXN
XXXXXXXXXXsetron (Zofran ODT)
Not given within
4 mg, DIS Tablet, PO, Q8H (Every 8 hoXXXXXXXXXXXXXXXs.XXXXXXXXVomiting, 10/18XXXXXXXX4:00 CDT,
10/1XXXXXXXXXXX00 CDT
ondansetron
Med Responses

PDF Page 25XXXXXXXXXX:01 a.m. 10-24-2023
25/42
Flowsheet Print Request
Patien
Printed byXXXXXXXXXXe Range: XXXXXXXXXX 09:19 - 10/25/2023XXXXXXXXXXnted onXXXXXXXXXXX3XXXXXXXXXXiXXXXXXXXXX/XXXXXXXXXX/XXXXXXXXXX/XXXXXXXXXX/24/2023
10/24/2023
09:00
08:30
08:29
08:05
0XXXXXXXheduled
amL.ODIPine
10 mXXXXXXXXPO, Daily, 10/18/23 11:13:00 CDT
At home, XXXXXXXXXXs taking mXXXXXXXXXXwith 046
amlodipine
10 ma Auth (Ve
bXXXXXXine topical (Orajel)
1 APP, GEL, TXXXXXXXXmes a day, 10/XXXXXXXXXX0:00
CDT
benzocaine topicXXXXXXXXXXXXXXXXer
cadexomXXXXXXXXXXXXXXXXl (cadexomer lodine
0.9
0.9XXXXXXXXOP, Daily, 10/21/23 9:00:00 CDT
XXXXXX
Cleanse the wounds with NS, paXXXXXXXXXXly lodos
10XXXXXXXXXXXXXXXXDT
cadexomeXXXXXXXXXXXpiXXXXXXXXXXXXXXXXXXXXXXXcycline monohydrate)
100 mg, CAP, PO, BID (2 times a day), Other-Enter
XXXXXXXX Comments, 10/18/23 11:15XXXXXXXX Stop
date 11XXXXXXXXXXX:00 CST
doxycyclXXXXXXXXXXXXXXXXXV
B
ferrous sulfate
325 mXXXXXXXXPO, Daily, 10/XXXXXXXXXXXXXXXCDT
ferrous sulfate
325 mq Auth (V
fluticasone nasXXXXX0 mcg, SPXXXXXXXXal, Daily, 10/XXXXXXXXXXX:XXXXXT
fluticasone naXXXXXXXXXXXXXutXXXXXXXXXXXXXXXXl (Haldol Decanoate)
100 mg, INJ, IM, Q4WEEXXXXXXXX 4 weeks),
10/18/23 7:18:00 CDT
At home. XXXXXXXXXXs takiXXXXXXXXXXXon with
haloperidol
Richmond Agitation-SedXXXXXXXXXXXXXXXXS)
XXXXXXXXXXX RXXXXXXhaloperidol (Haldol)
10 mg, TAB, PO, BIXXXXXXXXes a day), 10XXXXXXXXXXX:00 CDT
haloperidol
10 mq Auth (Ve
Richmond Agitation-SedXXXXXXXXXXXXXXXXS)
Respiratory Rate

PDF Page 2XXXXXXXXXX3:22 a.m. 10-24-2023
26/42
Flowsheet Print Request
Patier
Printed bXXXXXXXXXXte Range:XXXXXXXXXX3 09:19 - 10/25/202XXXXXXXXXXinted oXXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXXX/24/2023
Medications
09:00
08:3XXXXXXXXXXXXXXXX:03
insulin glargine
50 Unit, XXXXXXXXcut, Daily, 10/18/23 21:00:00 CDT
At home,XXXXXXXXXXas taking medication with
insulin glargine
Blood Glucose, MAR
2nd Clinician VerificaXXXXXXXXXXXXXXmin
R
Insulin lispro
18XXXXX, INJ, Subcut, TIDAC (3 times aXXXXXXXXore
meals), 10/18/23 10:00:00 CDT
At home.XXXXXXXXXXas takXXXXXXXXXXXXXX with
insulin lisXXXXXXXXXXXXX: Refu
Blood Glucose, MAR
2nd Clinician Verification Before AXXXXXXXXXX-200, U-3
lisinopril
10 XXXXXXXX PO, Daily, 10/18/23 11:14:00 CDT
--- At home,XXXXXXXXXXas taking XXXXXXXXXX with see
lisinoprXXXXXXXXXAuth (Ve
R
metFORMIN
1,000 mg, TAB, PO, BXXXXXXXXmes a day), 10/18/23
10:00:00 CDT
At home.XXXXXXXXXXAS takXXXXXXXXXation with
metFORXXXXXXXXXXven: Refu
OLANZapine
20 mg, TAB, POXXXXXXXXt bedtime), 10/18/23
21:00:00 CDT
At home,XXXXXXXXXXas takXXXXXXXXXXtion with
olanzapine
Richmond Agitation-Sedation Scale (RASS)
RespiXXXXXXXXXXXXXRN
PRN
acetaminophen
650 mg, TAB, PO, Q6H (XXXXy XXXXXXXX, PRN Pain,
10/XXXXXXXX:12:00 CDT, 10/18/23 10:12:00 CDT
At home,XXXXXXXXXXas takXXXXXXXXXXXXXn with
acetamXXXXhen
Location of PXXXXPain Site
AcuXXXXain Score
AcutXXXXin Goal
ChronicXXXXn Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-SeXXXXXXXXXXXXXXXXSS)
Respiratory Rate
Med Responses

PDF Page XXXXXXXXXX53:44 a.m.
10-24-2023
27/42
Flowsheet Print Request
Patier
Printed XXXXXXXXXXate RangeXXXXXXXXXX23 09:19 - 10/25/20XXXXXXXXXXrinted XXXXXXXXXXX0XXXXXXXXXXeXXXXXXXXXX1XXXXXXXXXX1XXXXXXXXXX1XXXXXXXXXX10/24/2023
10/24/2023
09:00
08:30
0XXXXXXXXX5
XXXXXXXXX
albuterol (albuterol inhaler)
180 mcg, INHALER, Inhalation, Q4H XXXXXXXXXXXXXXXXXXXN XXXXXXXXs of Breath, 10/18/23
10:12:00 XXXXXXXXXXXterol
PRN
benztropine
1 mg, INJ, IM, Q8H (Every 8 hours), PRN XXXXXXXXee
comment), 1XXXXXXXX1:22:00 CDT, 10/1XXXXXXXXX:00
CDT
PRNXXXXXXXXXXXAkethXXXXXXXXXXXXXXXXXPRN
calcium carbonate (Turns 500)
1,250 mg, CHEW TAB, Chewed, TID (3 times a XXXXXXXXN dvspepsia. 1XXXXXXXXXXXXXXXXXCDT
cXXXXXXXXarXXXXXX
PRN
docusate (Colace)
100 mg, CAP, PO, BID XXXXXXXXXXXXayXXXXXXXXonstipation, 10XXXXXXXX0:13:00 CDT. 1XXXXXXXX10.13.0XXXXXXXXXXXate
PRN XXXXXXXXXXXne nasal (fluticasone 50 mcg/lnh nas...
50 mcg, XXXXXay, SPRAY, BoXXXXXXXXXXDaXXXXXXXX
Congestion, 10/18/23 10:13:00 CDT
At homeXXXXXXXXXXwas taXXXXXXXXXXXtXXXXXith
fXXXXXXXXXXXnasal
PRN
haloperidol
5 mg, TAB, PO, Q8H XXXXXXXXXhoXXXXXXXXN Agitation,
XXXXXXXXXXX22:00 CDT
haloperidol
Richmond Agitation-Sedation Scale (RASS)
Respiratory RateXXXXXXXXXXXses
8
PRN
haloperidol
10 mg, INJ, IM, Q3H XXXXXXXXXhoXXXXXXXXN
Agitation, 10/18/23 1XXXXXXXXXX
Give this medication ONLY if patXXXXXXXXXXX toler...
haloperidol
Richmond Agitation-SXXXXXXXXXXXXXXXXASS)
Respiratory RaXXXXXXXXXspXXXXXXPRN
Ibuprofen (Motrin)
400 mg, TAB, PO, Q8H XXXXry 8 houXXXXXXXX Pain,
Mild, 10XXXXXXXX5:15:00 CDT, 1XXXXXXXXX5:15:00
CDT
ibuprofen

PDF PageXXXXXXXXXX:54:04 a.m.
10-24-2023
28/42
Flowsheet Print Request
Patie
PrinteXXXXXXXXXXDate RangXXXXXXXXXX023 09:19 - 10/25/2XXXXXXXXXXPrintedXXXXXXXXXX/XXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXX
XXXXXXXXXXX10/24/2023
Medications
09:00
08:30
08:29
08XXXX0XXXX
Location ofXXXXn
Pain Site
AXXXX Pain XXXXXXXXXXXXXXXXXXoal
ChronXXXXain Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond Agitation-XXXXXXXXXXXXXXXXRASS)
Respiratory RXXXXXXXXXXspXXXXXXXXXXXoperamide (Imodium A-D)
4 mg, CAP, PO, Q6H (Every 6 hourXXXXXXXXXXXneXXXXXXXX loose stool, 1XXXXXXXX10:13:00 CDT,
XXXXXXXXXX0:13:00 XXXXXXXXXamide
/8
PRN
LORazepam
1 mg, INJ, IM, Q6H (Every 6 hourXXXXXXX aXXXXXXXX
for anxiety, 10/18/23 XXXXXXXXXXT
Give this medication ONLY if paXXXXXXXXXnot toler...
LORazepam
Richmond Agitation-XXXXXXXXXXXXXXXXRASS)
Respiratory RatXXXXXXXXXponses
R
PRN
LORazepam
1 mg, TAB, PO, Q8H (Every 8 hourXXXXXXX aXXXXXXXX for anxiety,XXXXXXXXX 1:22:00 CDT
LORazepam
Richmond Agitation-Sedation Scale (RASS)
Respiratory RatXXXXXXXXXXXXXXXXXXXRN
magnesium hydroxide
2.4 GM,XXXXXXXXXXXXaiXXXXXXXXConstipation,
1XXXXXXXXXXXXXXXXCDXXXXXXXXXXXXXXXXXXXa)
magnesium hydroxXXXXXXXXXXXpoXXXXXXXXXXndansetron (Zofran ODT)
4 mg, DIS Tablet, PO, Q8HXXXXXXXXXXXXXXX)XXXXXXXXusea/Vomiting 1XXXXXXXX10:14:00 CDT,
XXXXXXXXXXX:14:00 CDT
ondansetron
Med Responses

PDF PagXXXXXXXXXX0XXXXX3 a.m.
10-24-2023
29/42
Flowsheet Print Request
PXXXXXXXXXX
Date RanXXXXXXXXXX2023 09:19 - 10/25/XXXXXXXXXX
PrinteXXXXXXXXXX4XXXXXXXXXX9XXXXXXXXXX3XXXXXXXXXX3XXXXXXXXXX3XXXXXXXXXXX
10/23/2023
Medications
20:59
20:41
17:00XXXXXXXXXX00
Scheduled
amLODIPine
XXXXXXXXAB, PO, Daily, 10/18/23 11:13:00 CDT
At hoXXXXXXXXXXt was XXXXXXXXXXXXXXXXXXXXXh
amlodipiXXXXXXzocaine topical (Orajel)
1 APP, GEXXXXXXXX4 times a day,XXXXXXXXXX17:00:00
CDT
benzocaine topical
1 APP AutXXXXXXXXXXXXXXXX: Othe
cadXXXXXXXXXXXXXXXXpical (cadexomer lodine ---XXXXXXXXL, TOP, Daily, 10/21/23 9XXXXXX CDT
Cleanse the wounds with NS,XXXXXXXXXXXXXXXXlodos.
cadexXXXXXXXXXXX tXXXXXXXXXXXXXXXXXXXXXXXdoxycycline monohydrate)
100 mg, CAP, PO, BID (2 times a day), Other-EnXXXXXXXXrder Comments, 10/18/23 1XXXXXXXXCDT, Stop
datXXXXXXXXXXX9:00:00 CST
doxycycXXXXXXXXXXXXXXXh (V
<9
ferrous sulfate
3XXXXXXXXAB, PO, Daily,XXXXXXXXXXXXXXX:XXXXXXXXXXXous sulfate
fluticasoneXXXXXl
100 mcgXXXXXXXX Nasal, Daily,XXXXXXXXXXXXXXXXXXXXXXXXXXXXXasXXXXXXXXXXXXXXXXridol (Haldol Decanoate)
100 mg, INJ, IM, QXXXXXXXXvery 4 weeks),
10/18/23 7:18:00 CDT
At hoXXXXXXXXXXt was XXXXXXXXXXXcation with
haloperidol
Richmond Agitation-Sedation Scale (XXXXXXXXXXXraXXXXXXate
haloperidol (Haldol)
10 mg, TAB, POXXXXXXXX times a day)XXXXXXXXXX
9:00:00 CDT
haloperido!
10 mq Auth (Ve
Richmond AgitationXXXXXXXXXXXXXXXX(RASS)
Respiratory Rate

PDF PaXXXXXXXXXX1XXXXX42 a.m.
10-24-2023
30/42
Flowsheet Print Request
XXXXXXXXXX:
Date RaXXXXXXXXXX/2023 09:19 - 10/25XXXXXXXXXX9
PrintXXXXXXXXXXX4XXXXXXXXXX9XXXXXXXXXXnXXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX23
10/23/2023
10/23/2023
20:59
XXXXXXXXXXXXXXXX0
16:00
insulin glargine
50 UnXXXXXXXX Subcut, Daily, 10/18/23 21:00:00 CDT
At hXXXXXXXXXXnt was takXXXXXXXXXXXXXXXXith ass
insulin glargine
50 Unit Auth (Vc
Blood Glucose, MAR
2nd Clinician Verification BeforXXXXXXXXXXXXXX100 Ins
&
insulin lispro
18 Unit, INJ, Subcut, TIDAC (3 timXXXXXXXX before
meals), 10/18/23 10:00:00 CDT
---
At hXXXXXXXXXXnt wasXXXXXXXXXXXXXXtion with
insulin lispro
Not Given: Refu
Blood Glucose, MAR
2nd Clinician Verification BefXXXXXXXXXXN/A U-100 ins
disinoprilXXXXXXXXTAB, PO, Daily, 10/18/23 11:14:00 CDT
At hXXXXXXXXXXnt wasXXXXXXXXXXdicXXXXXXXXXh
lisinopril
R
metFORMIN
1,000 mg, TAB, PXXXXXXXX2 times a day), 10/18/23
10:00:00 CDT
At hXXXXXXXXXXnt wasXXXXXXXXXedication with
meXXXXXXXXXXt Given: Refu
OLANZapine
20 mg, TABXXXXXXXXS (At bedtime), 10/18/23
21:00:00 CDT
At hXXXXXXXXXXnt wasXXXXXXXXXXdication with
olanzapine
20 mg Auth (Ve
Richmond AgitatioXXXXXXXXXXXXXXXX (RASS)
ResXXXXXXXXXXXXX
PRN
B
PRN
acetaminophen
650 mg, TAB, PO, QXXXXEvXXXXXXXXurs), PRN Pain,XXXXXXXX3 10:12:00 CDT, 10/18/23 10:12:00 CDT
At hXXXXXXXXXXnt wasXXXXXXXXXXXXXation with
acXXXXiXXXXen
Location XXXXain
Pain SiteXXXXte PaiXXXXXXXXXXXXXXXXXX Goal
ChrXXXX Pain Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond AgitatioXXXXXXXXXXXXXXXX (RASS)
Respiratory Rate
Med Responses

PDF PXXXXXXXXXX
10:55:04 a.m.
10-24-2023
31 1/42
Flowsheet Print Request
Patient
PrinXXXXXXXXXXN:
Date RXXXXXXXXXX3/2023 09:19 - 10/2XXXXXXXXXX19
PrinXXXXXXXXXX/XXXXXXXXXX:XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXX0XXXXXXXXXXX23
10/23/2023
Medications
20:59
20:XXXXXXXXX16XXXXXXXXX
PRN
albuterol (albuterol inhaler)
180 mcg, INHALER, Inhalation, XXXXXXXXXXXXXXXXXXX, XXXXXXXXtness of BreatXXXXXXXXX23
10XXXXXXXXXXXalbuterol
PRN
benztropine
1 mg, INJ, IM, Q8H (Every 8 hours), XXXXXXXXr (see
commentXXXXXXXX/23 1:22:00 CDT, XXXXXXXXX1XXXXXXXXXTXXXXXXXXXXXess/AXXXXXXXXXXXXXXXXXinXXXXN
calcium carbonate (Tums 500)
1,250 mg, CHEW TAB, Chewed, XXXXXXXXXmeXXXXXXXX,
PRN dvspensiXXXXXXXXXXXXXXXXX:00 CXXXXXXXXumXXXXXXnate
PRN
docusate (Colace)
100 mg, CAP, PO, XXXXXXXXXXXX aXXXXXXXXRN
ConstipationXXXXXXXX23 10:13:00 CDXXXXXXXX/23
1XXXXXXXXXXXXXXXXXXteXXXXXXXXXXXasone riasal (fluticasone 50 mcg/lnh nas...
50 mXXXXX Spray, SPRAYXXXXXXXXXXesXXXXXXXX PRN
Congestion, 10/18/23 10:13:00 CDT
At XXXXXXXXXXent waXXXXXXXXXXXdication with
XXXXXXXXXXX nasal
18
PRN
haloperidol
5 mg, TAB, PO, XXXXXXXXXy XXXXXXXX, PRN AgitatiXXXXXXXXXXX3 1:22:00 XXXXXXXXXeridol
Richmond AgitatiXXXXXXXXXXXXXXXXe (RASS)
Respiratory RXXXXXXXXXXXponses
KB
PRN
haloperidol
10 mg, INJ, IM, XXXXXXXXXy XXXXXXXX, PRN
Agitation, 10/18/XXXXXXXXXX CDT
Give this medication ONLY ifXXXXXXXXXXXnnot toler...
haloperidol
Richmond AgitatiXXXXXXXXXXXXXXXXe (RASS)
RespiratorXXXXXXXXXd XXXXXXses
PRN
ibuprofen (Motrin)
400 mg, TAB, PO. XXXX(Every 8XXXXXXXX PRN Pain,
MildXXXXXXXX23 15:15:00 CDXXXXXXXXX23 15:15:00
CDT
ibuprofen

PDF XXXXXXXXXX3
10:55:24 a.m.
10-24-2023
32/42
Flowsheet Print Request
Patient:
PrXXXXXXXXXXMRN
Date XXXXXXXXXX23/2023 09:19 - 10/XXXXXXXXXX:19
PriXXXXXXXXXXX/XXXXXXXXXX:XXXXXXXXXXiXXXXXXXXXX2XXXXXXXXXX2XXXXXXXXXX2023
10/23/2023
10/23/2023
20:59
20:41
17:0XXXX:30
16:00
LocatioXXXX Pain
Pain SiXXXXcute Pain ScorXXXXute Pain Goal
CXXXXic Pain Score
Chronic PXXXXGoal
Wong-Baker FACES Pain Rating Scale
Richmond AgltatXXXXXXXXXXXXXXXXle (RASS)
RespiratoryXXXXXXXXXXReXXXXXXXXXXXRN
loperamide (Imodium A-D)
4 mg, CAP, PO, Q6H (Every 6 XXXXXXXXXXX aXXXXXXXX for loose stooXXXXXXXX/23 10:13:00 CXXXXXXXXXX23 10:13XXXXXXXXXoperamide
/8
PRN
LORazepam
1 mg, INJ. IM, Q6H (Every 6 XXXXXXX PXXXXXXXXeded
for anxiety, 10/18XXXXXXXXXX0 CDT
Give this medication ONLXXXXXXXXXent cannot toler
LORazepam
Richmond Agitation-Sedation Scale (RASS)
Respiratory RaXXXXXXXXXsponses
8
to
PRN
LORazepam
1 mg, TAB, PO, Q8H (Every 8 XXXXXXX PXXXXXXXXeded for anxiXXXXXXXXX8/23 1:22:00 CDT
LORazepam
Richmond Agitation-Sedation Scale (RASS)
Respiratory XXXXXXXXXXXXXXXXXXXKE
PRN
magnesium hydroxide
2.4XXXXXXXXXXXXO,XXXXXXXXPRN ConstipatioXXXXXXXXXXXXXXXX:0XXXXXXXXXXXXXXXXXXXnesia)
magnesium hyXXXXXXXXXXX RXXXXXXXXXXRN
ondansetron (Zofran ODT)
4 mg, DIS Tablet, PO,XXXXXXXXXXXXXXXoXXXXXXXXN
Nausea/VomitiXXXXXXXX/23 10:14:00 CDT,
10/18/23 10-14-00 CDT
ondansetron
Med Responses

PDFXXXXXXXXXX23
10:55:43 a.m.
10-24-2023
33/42
Flowsheet Print Request
Patient:
PrXXXXXXXXXXMRN:
DateXXXXXXXXXX/23/2023 09:19 - 10XXXXXXXXXX9:19
PrXXXXXXXXXXX0XXXXXXXXXX9XXXXXXXXXXtXXXXXXXXXX/2023
10/23/2023
10/23/2023
1XXXXXXXXXX 12:13
Scheduled
amLODIPXXXXXXXXg, TAB, PO, Daily, 10/18/23 11:13:00 CDT
AXXXXXXXXXXtient XXXXXXXXXXXXXXXXXXXXX with
amloXXXXXX
benzocaine topical (Orajel)
1 APPXXXXXXXXOP, 4 times a XXXXXXXXXX/23 17:00XXXXXXXXXXXXXXXXne topicalXXXXXXXXXXXXXXXXe topical (cadexomer jodineXXXXXXXX, GEL, TOP, Daily, 10/21/XXXXXX0:00 CDT
Cleanse the wounds with XXXXXXXXXXXXXXXXly lodos..
XXXXXXXXXXXodXXXXXXXXXXXXXXXXXXXXXXXne (doxycycline monohydrate)
100 mg, CAP, PO, BID (2 times a day), OtheXXXXXXXXin Order Comments, 10/18/XXXXXXXX:00 CDT, StopXXXXXXXXXXX/23XXXXXXXXXXXXXXXxycycline
8
ferrous sulfaXXXXXXXXg, TAB, PO, DaXXXXXXXXXXXXXXX1XXXXXXXXXXXferrous sulfate
fluticaXXXXXnasal
100XXXXXXXXRAY, Nasal, DaXXXXXXXXXXXXXXXXXXXX0XXXXXXXXXXXcaXXXXXXXXXXXXXXXXloperidol (Haldol Decanoate)
100 mg, INJ, IXXXXXXXXK (Every 4 weeks),
10/18/23 7:18:00 CDT
--- AXXXXXXXXXXtient XXXXXXXXXXXmedication with
haloperidol
Richmond AgitaXXXXXXXXXXXXXXXXaleXXXXXXXXXXXpiXXXXXX Rate
8
haloperidol (Haldol)
10 mg, TABXXXXXXXXD (2 times a day), 10/22/23
9:00:00 CDT
haloperidol
Richmond AgitaXXXXXXXXXXXXXXXXale (RASS)
Respiratory Rate

PDXXXXXXXXXX123
10:56:01 a.m. 10-24-2023
34/42
Flowsheet Print Request
Patient
PXXXXXXXXXX
MRN:
DatXXXXXXXXXX0/23/2023 09:19 - 1XXXXXXXXXX09:19
PXXXXXXXXXX XXXXXXXXXX XXXXXXXXXX3XXXXXXXXXXX/2023
10/23/2023
MedicXXXXXXXXXXXXXXXX46
12:13
18
Insulin glargine
5XXXXXXXXINJ, Subcut, Daily, 10/18/23 21:00:00 CDT
XXXXXXXXXXatient was taking medication with
insulin glargine
Blood Glucose, MAR
2nd CliniciaXXXXXXXXXXXXXX Before Admin
Insulin lXXXXX
18 Unit, INJ, Subcut, TIDAC (3XXXXXXXX day before
meals), 10/18/23 10:00:00 CDT
--- XXXXXXXXXXatient waXXXXXXXXXXXXXXation with ..
insulin lispro
18 Unit Auth (V
Blood Glucose, MAR
2nd Clinician VerificationXXXXXXXXXXmin
N/A U-100 ins
lisinoXXXXXXXXmg, TAB, PO, Daily, 10/18/23 11:14:00 CDT
---
XXXXXXXXXXatient wasXXXXXXXXXXdXXXXXXXXXith 400
disinopril
metFORMIN
1,000 mg, TAXXXXXXXXID (2 times a day), 10/18/23
10:00:00 CDT
XXXXXXXXXXatientXXXXXXXXXnXXXXXXXXXXon with
metFORMIN
OLANZapine
20 mg,XXXXXXXX, QHS (At bedtime), 10/18/23
21:00:00 CDT
XXXXXXXXXXatient wXXXXXXXXXXmedication with -
olanzapine
Richmond AgitXXXXXXXXXXXXXXXXcale (RASXXXXXXXXXXXXXy Rate
PRN
PRN
acetaminophen
650 mg, TAB, PXXXX6HXXXXXXXX6 hours), PRN PXXXXXXXX18/23 10:12:00 CDT, 10/18/23 10:12:00 CDT
XXXXXXXXXXatient wXXXXXXXXXXXXXication with -
acetaminophen
XXXX0 mg Auth (
LocatXXXXXXXXXXn
Pain Site
Acute Pain SXXXX
9 Auth (VerifXXXXAcute Pain GoalXXXXonic Pain Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond AgitXXXXXXXXXXXXXXXXcale (RASS)
Respiratory Rate
Med Responses
Med Response ,

PXXXXXXXXXX
123
10:56:22 a.m.
10-24-2023
35/42
Flowsheet Print Request
Patient
XXXXXXXXXX:
MRN:
DaXXXXXXXXXX10/23/2023 09:19 - XXXXXXXXXX 09:19
XXXXXXXXXX:XXXXXXXXXX3XXXXXXXXXX2XXXXXXXXXXX3/2023
10/23/2023
MedicXXXXXXXXX:4XXXXXXXXX2:13
PRN
albuterol (albuterol inhaler)
180 mcg, INHALER, InhalatiXXXXXXXXXXXXXXXXXXXurXXXXXXXXShortness of BXXXXXXXXX/18/2XXXXXXXXXXXCDT
albuterol
PRN
benztropine
1 mg, INJ, IM, Q8H (Every 8 hourXXXXXXXXOther (see
comXXXXXXXX0/18/23 1:22:00 CXXXXXXXXX/23 1:22:00XXXXXXXXXXXiffneXXXXXXXXXXXXXXXXXtrXXXXe
PRN
calcium carbonate (Tums 500)
1,250 mg, CHEW TAB, ChewXXXXXXXXX3 XXXXXXXXday),
PRN dvspXXXXXXXXXXXXXXXXX0:14:XXXXXXXXalXXXXXXarbonate
PRN
docusate (Colace)
100 mg, CAP, XXXXXXXXXXXXimXXXXXXXX), PRN
ConstipaXXXXXXXX/18/23 10:13:0XXXXXXXX0/18/XXXXXXXXXXXXXXXXXocXXXXXXXXXXXluticasone nasal (fluticasone 50 mcg/Inh nas...
XXXXXg, 1 Spray, SXXXXXXXXXX NXXXXXXXXily, PRN
Congestion, 10/18/23 10:13:00 CDT
:XXXXXXXXXXpatienXXXXXXXXXXXgXXXXXcation XXXXXXXXXXXasone nasal
2
PRN
haloperidol
5 mg, TAB, XXXXXXXXXEvXXXXXXXXurs), PRN AgiXXXXXXXXXXX18/23 1:22:00 CDT
haloperidol
Richmond Agitation-Sedation Scale (RASS)
RespiratXXXXXXXXXXXd Responses
B
PRN
haloperidol
10 mg, INJ, XXXXXXXXXEvXXXXXXXXurs), PRN
Agitation, 10XXXXXXXXXX2:00 CDT
Give this medication ONLXXXXXXXXXXXt cannot toler...
haloperidol
Richmond Agitation-Sedation Scale (RASS)
RespirXXXXXXXXXe
XXXXXXsponses
PRN
ibuprofen (Motrin)
400 mg, TAB, XXXXQ8H (EveXXXXXXXXrs), PRN Pain,
XXXXXXXX/23/23 15:15:0XXXXXXXXX/23/23 15:15:00
CDT
ibuprofen

XXXXXXXXXX6
123
10:56:42 a.m.
10-24-2023
36/42
Flowsheet Print Request
PatienXXXXXXXXXXy:
MRN:
DXXXXXXXXXX 10/23/2023 09:19 -XXXXXXXXXX3 09:19XXXXXXXXXXX:XXXXXXXXXX3XXXXXXXXXXiXXXXXXXXXX/23/2023
10/23/2023
10/23/2023
XXXX6
12:46
12:13
LocXXXXn of Pain
PaiXXXXte
Acute Pain XXXXe
Acute Pain GoXXXXhronic Pain Score
Chronic Pain Goal
Wong-Baker FACES Pain Rating Scale
Richmond AgXXXXXXXXXXXXXXXX Scale (RASS)
RespiraXXXXXXXXXXMeXXXXXXXnses
R
PRN
loperamide (Imodium A-D)
4 mg, CAP, PO, Q6H (EverXXXXXXXXXXX PXXXXXXXXeded for loose XXXXXXXX0/18/23 10:13:XXXXXXXXXX/18/23 XXXXXXXXXCDT
loperamide
8
PRN
LORazepam
1 mg, INJ, IM, Q6H (EverXXXXXXXrsXXXXXXXXs needed
for anxiety, 1XXXXXXXXXX22:00 CDT
Give this medicationXXXXXXXXXpatient cannot tnler
LORazepam
Richmond Agitation-Sedation Scale (RASS)
RespiraXXXXXXXXX
Med Responses
R
PRN
LORazepam
1 mg, TAB, PO, Q8H (EverXXXXXXXrsXXXXXXXXs
needed for XXXXXXXXX10/18/23 1XXXXXXXXXT
LORazepam
Richmond Agitation-Sedation Scale (RASS)
RespiratXXXXXXXXXXXXXXXXXXXses
/8
PRN
magnesium hydroxideXXXXXXXXXXXXP,XXXXXXXXly, PRN ConstipXXXXXXXXXXXXXXXX1:XXXXXXXXXXXXXXXXXXX Magnesia)
magnesiuXXXXXXXXXXX
MXXXXXXXXXXes
PRN
ondansetron (Zofran ODT)
4 mg, DIS Tablet,XXXXXXXXXXXXXXX XXXXXXXX, PRN
Nausea/Vomiting 10/18XXXXXXXX4:00 CDT,
PDF XXXXXXXXXXX18/23 10-14-00 CDT
ondansetron
Med Responses
XXXXXXXXXX38
123
10:57:00 a.m. 10-24-2023
37/42
BH MTPXXXXXXXX Care Shift Assessment
10/23/23 16:31 CDT PXXXXXXXX by
RN,CPI,
Entered on 10/23/23 16:34 CDT
XXXXXXXXXXXXXBH MTP Problem 1: schizophrenia and ineffective coping
BH MTP Problem 1 Status: ActXXXXXXXMTXXXXXXXXXXXXXymptoms: Bipolar, Schizophrenia/Psychotic
BH MTP ProblXXXXXXXXXXXXXXXXXXXot show any aggressive behavior once while admitted
BH MTPXXXXXXXX 1 Goal Target Date 1: 10/25/23
BH MTP Problem 1 Goal Type 1: Short term
BH MTP Problem 1 Goal Status 1: Not progressing
BH MTP Problem 1 Goal 1 Grid
BH MTP Problem 1
Intervention 1
Allow patient to
Encourage patient to
verbalize
reframe/refute
frustrations
negative thoughts
BH MTP Problem 1
Discipline 1
Team
Team
BH MTP Problem 1
Frequency 1
q shift
q shift
BH MTP Problem 1
Duration 1
7 days
7 days
BH MTP Problem 1
Status 1
Done
Done
BH MTP Problem 1 Goal 2:
XXXX be compliant with ordered meds here and after discharge
BH MTPXXXXXXXX 1 Goal Target Date 2: 11/01/23
BH MTP Problem 1 Goal Type 2: Long term
BH MTP Problem 1 Goal Status 2: Progressing
BH MTP Problem 1 Goal 2 Grid
BH MTP Problem 1
Intervention 2
RN will explain
Assess patient's
purpoXXXXXXXXXX
thought process and
medication
current level of
administered and
psycho
BH MTP Problem 1
Discipline 2
Team
Team
BH MTP Problem 1
Frequency 2
q shift
q shift
BH MTP Problem 1
Duration 2
until discharge
until discharge
BH MTP Problem 1
Status 2
Done
Done
POC Shift Narrative
BXXXXXXX NXXXXXXXXXXPtXXXXXXXXXXXXXXXXXXXXXXXXioXXXXXXavXXXXXXXXuent XXXXXXXX, labile, paraXXXXXXXXXXestless. Pt has been medication compliant wiXXXXXXXXXXXXints of medication side effects. Pt
attended partiXXXXXoups. PtXXXXXXXXXXXXXXies SI/HI or A/V hallucinations but has been responding to
internal stimuli.
A)
XXtient NXXXXXXOB 7 AGE 7 SEX:
39 Years Female
Admitting Physician:
AdmissiXXXXXXXX/ MRN 7 FinanXXXXXXXX: 10/18/23

Print Date: 10/24/23
Print Time: 10:26 CDT
Printed bXXXXXXXXXX 39
123
10:57:25 a.m.
10-24-2023
38/4XXXXXXXXXX 40
123
10:57:32 a.m. 10-24-2023
39/42
BH MTXXXXXXXXf Care Shift Assessment
10/22/23 04:57 CDT XXXXXXXXd by
RN,CPI,
Entered on 10/22/23 05:00 CDTXXXXXXXXXXXXX
BH MTP Problem 1: schizophrenia and ineffective coping
BH MTP Problem 1 Status: Active
BH BH MTP MTP ProbleXXXXXXXem 1 1 XXXXXXXXXXXXXlXXXXXXXXXar, will SchizXXXXXXXXXXXXXXXXXXXnot show any aggressive behavior once while admitted
BH MTXXXXXXXXm 1 Goal Target Date 1: 10/25/23
BH MTP Problem 1 Goal Type 1: Short term
BH MTP Problem 1 Goal Status 1: Progressing
BH MTP Problem 1 Goal 1 Grid
BH MTP Problem 1
Intervention 1
Allow patient to
Encourage patient to
verbalize
reframe/refute
frustrations
negative thoughts
BH MTP Problem 1
Discipline 1
Team
Team
BH MTP Problem 1
Frequency 1
q shift
q shift
BH MTP Problem 1
Duration 1
7 days
7 days
BH MTP Problem 1
Status 1
Done
Done
BH MTP Problem 1 Goal 2:XXXXl be compliant with ordered meds here and after discharge
BH MTXXXXXXXXm 1 Goal Target Date 2: 11/01/23
BH MTP Problem 1 Goal Type 2: Long term
BH MTP Problem 1 Goal Status 2: Progressing
BH MTP Problem 1 Goal 2 Grid
BH MTP Problem 1
Intervention 2
RN will explain
Assess patient's
purpXXXXXXXXXXh
thought process and
medication
current level of
administered and
psycho
BH MTP Problem 1
Discipline 2
Team
Team
BH MTP Problem 1
Frequency 2
a shift
q shift
BH MTP Problem 1
Duration 2
until discharge
until discharge
BH MTP Problem 1
Status 2
Done
Done
POC Shift Narrative
BH Shift Narrative: Pt has been isolative to her room, guarded , no group attendanXXXXXXXXXXXXXXXXth
her HS meds, slept on and off during the night, attention-seeking and nXXXXXXXocused onXXXXXXXXXnacks, aXXXXXXXXeasily irritable, given PRN meds, rXXXXXXXXble;XXXXXXXXXXXXXXXXute distress nd
untoard behavior.XXatient XXXXXXDOB / AGE / SEX:
39 Years Female
Admitting Physici
AdmissXXXXXXXX / MRN / FinaXXXXXXXXm: 10/18/23

Print Date: 10/24/23
Print Time: 10:27 CDT
Printed XXXXXXXXXXe 41
123
10:57:57 a.m.
10-24-2023
40/XXXXXXXXXXe 42
123
10:58:05 a.m.
10-24-2023
41/42
BH MXXXXXXXXof Care Shift Assessment
10/20/23 05:27 CDT XXXXXXXXd by
RN, CPI,
Entered on 10/20/23 05:35 CDXXXXXXXXXXXXX1
BH MTP Problem XXXXXXizophrenia and ineffective coping
BH MTP Problem 1 Status: AXXXXXXXH XXXXXXXXXXXXX XXXXXXXXXXXXpolar, Schizophrenia/Psychotic
BH MTP Problem 1 Goal 1:
will not show any aggressive behavior once while admitted
BH MXXXXXXXXem 1 Goal Target Date 1: 10/25/23
BH MTP Problem 1 Goal Type 1: Short term
BH MTP Problem 1 Goal Status 1: Progressing
BH MTP Problem 1 Goal 1 Grid
BH MTP Problem 1
Intervention 1
Allow patient to
Encourage patient to
verbalize
reframe/refute
frustrations
negative thoughts
BH MTP Problem 1
Discipline 1
Team
Team
BH MTP Problem 1
Frequency 1
q shift
q shift
BH MTP Problem 1
Duration 1
7 days
7 days
BH MTP Problem 1 Goal 2XXXXll be compliant with ordered meds here and after discharge
BH MXXXXXXXXem 1 Goal Target Date 2: 11/01/23
BH MTP Problem 1 Goal Type 2: Long term
BH MTP Problem 1 Goal Status 2: Progressing
BH MTP Problem 1 Goal 2 Grid
BH MTP Problem 1
Intervention 2
RN will explain
Assess patient's
purXXXXXXXXXXch
thought process and
medication
current level of
administered and
psycho
BH MTP Problem 1
Discipline 2
Team
Team
BH MTP Problem 1
Frequency 2
q shift
q shift
BH MTP Problem 1
Duration 2
until discharge
until discharge
POC Shift XXXXatXXXXXXXXXXftXXXXXXXXveXXXXXXXXXXXXelXXXXXXX, parXXXXXXXXXXXXXXXonal, defiant. Pt can becoXXXXXXX at
tXXXXXXXXXXstant with insulin and accuchecks stating "I don't need it, i'm fine without it" StaffXXXXXXXo redirect XXXXXXXXXXXXXXXXXXXXXX aXXXXXlow blood XXXXr monitoring. Wound on right foot
assessed and documented. Pt observed to sit in bathroom, turn shower on and read book. Pt
redirected from behavior, unstanding at that time. Woke up early morning XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXnd responding to XXXXXXXXXXXimuli. Complaint with medications, denie si/hi. Monitored q15
minutes for safety and well-beingXXPatientXXXXXX
DOB / AGE / SEX:
39 Years Female
Admitting Physician:
AdmisXXXXXXXXe / MRN 7 FinXXXXXXXXUM: 10/18/23

Print Date: 10/24/23
Print Time: 10:31 CDT
Printed by